arthritis (RA) were tested for RF specificity towards these IgG monoclonal anti-D antibodies the incidence and titre of reactivity towards an IgG3 monoclonal anti-D antibody was considerably greater than for a polyclonal anti-D antibody of the same Gm allotype, G3m(5). This difference was not explained by the amount of each anti-D antibody which bound to erythrocytes. Furthermore, when patients with RA were divided into groups according to their Gm phenotype, sera from a greater proportion of patients negative for the phenotype G3m(5) reacted to the G3m(5) monoclonal anti-D antibodies than sera from those patients positive for this allotype. Analysis of RF reactivities towards two IgG3 and three IgGl monoclonal anti-D antibodies, each with different Gm allotypic epitopes, indicated, however, that individual serum samples contained RFs with a spectrum of specificities; some sera appeared to react to a single set of Gm alleles, whereas others also reacted to isotypic or iso-allotypic epitopes, or both. Our data suggest that RFs with specificity for Gm allotypes do not arise in patients who carry that particular allotype owing to tolerance induced in fetal-neonatal life. Conversely, RFs with apparent specificity for a Gm allotype formed in patients negative for that allotype may be reacting to a closely related but different epitope. Final proof requires precise specificities for each RF formed, and IgG3 monoclonal anti-D antibodies would be useful reagents for this purpose.
Rheumatoid factor specificity for Gm allotypes 899 patients or normal individuals, were frequently negative for that allotype.
Recently we have developed an assay for determination of RF specificities, in which monoclonal IgG anti-Rh(D) antibodies of known subclass and Gm allotype are used as antigens for RF in the direct haemagglutination test. 7 With this assay system we showed first, that the incidence of reactivity in rheumatoid sera to an IgG3 monoclonal anti-D antibody of G3m (21) allotype is far greater than the reactivity to a polyclonal anti-D antibody of the same subclass and allotype. Secondly, and again using unseparated polyclonal RA sera, we found that the incidence of RFs reactive to monoclonal antibodies of the G3m(21) allotype was significantly greater in patients with RA negative for G3m (21) than in patients positive for this allotype. 7 We report here that the converse also applies. We find that the incidence of RFs reactive to an IgG3 monoclonal anti-D antibody of the opposite allele, namely G3m (5) , is significantly greater in sera from patients with RA negative for G3m(5) than in patients positive for G3m (5) .
Materials and methods

MONOCLONAL ANTI-Rh(D) ANTIBODIES
The two G3m(5) monoclonal anti-D antibodies (FOG3 and GAD2) were produced using heterohybridomas. 8 The four monoclonal anti-D antibodies -namely, CB6 (G3m(21)), AB5 (Glm (1, 17) ), IA3 (Glm(3)), and H27 (Glm(1,2,17))-were produced by Epstein-Barr virus transformed B lymphoblastic cell lines.9 9a POLYCLONAL ANTI-Rh(D) SERA Two human sera ('b' and 'g') containing either G3m (5) or G3m (21) anti-D antibodies respectively were purchased from the Central Laboratory of the Netherlands, Amsterdam, as allotyping reagents for these two Gm allotypes. We were unable to demonstrate IgGl or IgG2 anti-D antibodies (unpublished data) or IgG3 anti-D antibodies with the opposite allele ( The antibody was affinity purified on a SepharoseIgG column before iodination. The original washing procedure was modified in that after incubation and one wash in PBS the cell suspension was layered over a mixture of four parts dibutyl phthalate: one part dinonyl-n-butyl phthalate and briefly centrifuged, causing sedimentation of the cells through the oil.12 The tubes were then frozen and the tip containing the cell button cut off and counted. The number of IgG molecules per cell was calculated from the amount of anti-IgG bound (derived from the specific radioactivity of the labelled material), the cell count, and Avogadro's number. The (Table 3) . Sera were tested against three IgGl monoclonal anti-D antibodies-namely, AB5 (Glm (1,17) ), IA3 (Glm(3)), and H27 (Glm (1,2,17) ). Because reactivities were as random for IgGl as for IgG3 monoclonal anti-D antibodies the IgGl results were pooled. Unexpectedly, of the nine sera which reacted to the Glm(1,2 17) anti-D antibody (H27), only three also reacted to the Glm(1,17) anti-D antibody (AB5). and H27 (Glm (1,2,17) ).
bound to erythrocytes. Indeed the concentration of
G3m (5) (Table 3) . Until recently attention has largely focused on common autoantigenic epitopes for IgM RF, such as 'Ga'13 located within the Fc region of IgGl, 2, and 4, and on the presence of cross reactive idiotypes on monoclonal and polyclonal RFs.14 15 When the amount of RF with cross reactive idiotype was evaluated as a proportion of total polyclonal RF in individual patients with RA, however, it was found to represent a small fraction (<5%) of the total polyclonal RF idiotype population. 16 From this result the conclusion was drawn that an individual's repertoire of RF is mostly private, quite diverse, and unique to that individual, 6 and our results endorse this view (Table 3 ). In our previous study we attempted to Gm allele can only be tentative. We concluded in our previous publication that immune tolerance must prevent the appearance of clones producing antibodies to a particular G3m allelic epitope in patients who express that allele.7 This conclusion was drawn by analogy with polyclonal antiblood group A and B antibodies in normal individuals where tolerance prevents the production of natural antibodies to the B antigen in individuals with B or AB blood type, though these individuals form antibodies to Galal->3 Gal, a similar but nonfucosylated epitope.'7 Unexpectedly we found that considerably fewer heterozygous patients than homozygous patients reacted to a particular monoclonal anti-D antibody ( Table 2 ). The reverse had been expected, that patients homozygous for G3m (5) would be more effectively tolerant than the heterozygous patients and therefore that fewer homozygous patients would react to G3m(5) monoclonal anti-D antibodies. When other reactivities were considered (Table 3) , however, we concluded that heterozygous patients, who express a wider range of Gm allelic epitopes, must be tolerant to more of the complex range of RF specificities involved.
We are unable to explain satisfactorily the converse situation-namely, the apparent RF response to Gm epitopes in patients who do not carry that allele. We have already suggested transplacental or neonatal sensitisation as one of several possible explanations.7
An alternative might be somatic mutation of rearranged germline variable region immunoglobulin genes. It has been proposed that autoantibodies may arise by somatic mutation of germline genes which originally encoded antibodies that recognised foreign antigens.18 Indeed evidence in mice has shown that a somatic mutant of a mouse myeloma cell line results in the production of immunoglobulin which has changed by a single amino acid with a consequent change of antibody specificity from antiphosphocholine (an antibacterial specificity) to an autoantibody with reactivity to double stranded DNA and cardiolipin. 
